Navigation Links
A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
Date:9/4/2007

COLD SPRING HARBOR, N.Y. (Tues., Sept. 4, 2007) Skin cancer is the most prevalent form of human cancer in the United States, according to the Centers for Disease Control. But in order to more fully understand skin cancer in humans, scientists must use model organisms, such as mice, to study the disease in the laboratory.

This months release of Cold Spring Harbor Protocols (www.cshprotocols.org) includes free access to a protocol for generating mice with squamous cell carcinoma (SCC), one of the most common types of skin cancer. The procedure involves injecting mice with a drug called DMBA, which mutates (and thereby activates) a tumor-promoting gene. A second drug, called TPA, then encourages the proliferation of cells that carry the mutated gene. The resulting mass of cells is a tumor.

The protocol, freely available at http://www.cshprotocols.org/cgi/content/full/2007/18/pdb.prot4837, describes how to monitor and evaluate the mice for clinical signs of tumorigenesis. It also includes methods for preparing the tumor tissues for histological analysis, which allows scientists to study characteristics of the tumors at a microscopic level.

The protocol is from Dr. Michael Girardis group at the Yale University School of Medicine (http://info.med.yale.edu/dermatology/dept/girardi.html). Girardis team has used the procedure to examine the role of the immune system in susceptibility to SCC. It can also be used to test other physiological and environmental factors that may influence the growth and progression of skin cancer in mice, and will ultimately help scientists to better understand and control the disease in humans.

Also freely available from Cold Spring Harbor Protocols this month is an article that describes an efficient method for testing individuals for specific DNA variations called SNPs (single-nucleotide polymorphisms) (http://www.cshprotocols.org/cgi/content/full/2007/18/pdb.prot4843). The method, called the oligonucleotide ligation assay (OLA), will be useful for identifying individuals with disease-related mutations and other genetic variants. It was contributed by Dr. Stuart Macdonald from the University of Kansas (http://web.ku.edu/sjmac/).


'/>"/>

Contact: Maria Smit
smit@cshl.edu
516-422-4127
Cold Spring Harbor Laboratory
Source:Eurekalert

Related medicine news :

1. Ultrasound may mean end to classic stethoscope
2. New methods to prevent injury of patients
3. A new method to help smokers quit
4. Methods to have a flat stomach
5. Bioengineering production strains - Microbia develops new methods
6. New method of measuring arterial stiffness in elderly hypertensives
7. Easier Methods Required to Screen Insulin Resistance
8. Easier Methods Required to Screen Insulin Resistance
9. Accuracy of Some Natural Family Planning Methods Questioned .
10. New Method Of Delivering Chemotherapy
11. Adopting Easier Methods To Screen Insulin Resistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... July 26, 2017 , ... BioPlus Specialty Pharmacy ... updated version of the HCV Treatment Path app (version 4.4.0) to keep health ... (HCV) infection. All of the latest HCV medications are included in this app, ...
(Date:7/25/2017)... ... July 25, 2017 , ... “Now Hiring!” is a popular phrase ... The company has achieved record-breaking sales for over 30 consecutive years and now plans ... , The upcoming year offers excitement and growth at HDIS, following the company’s acquisition ...
(Date:7/25/2017)... ... July 25, 2017 , ... Centurion Service ... as Regional Account Manager for the Northeast and Florida regions. In this role, ... their obsolete medical assets. , Jennifer joins Centurion with a wealth of knowledge ...
(Date:7/25/2017)... (PRWEB) , ... July 25, 2017 , ... ... protection assistance and finance management services to communities across North Carolina, is launching ... Advocacy Network to raise community support for the ongoing fight against bladder cancer. ...
(Date:7/25/2017)... ... July 25, 2017 , ... Dr. Donna Bergman, ... recently co-authored and published an article in the medical science journal Physical Medicine ... Both the article and the research that helped produce it, were written and ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... , July 13, 2017 RK Logistics Group, Inc. ... Pharmacy certification for its Fremont, CA ... in the Tri-Valley and San Jose ... City of Fremont , with its Fremont Innovation District, ... provide such a powerful resource to the hundreds of biotech, ...
(Date:7/11/2017)... 2017 Zymo Research Corp., also known as ,The Epigenetics Company, ... aging in a precise manner using the myDNAge ™ test. Based ... professor of human genetics and biostatistics at the David Geffen School ... , Zymo Research,s proprietary DNAge ™ technology is used to analyze ... ...
(Date:7/11/2017)... Echenberg, founder of Echenberg Institute, is announcing a new safe and effective ... intercourse and other painful pelvic pain conditions such as pelvic floor dysfunction, ... ... ... -based start-up company, VuVatech LLC, fills a void in the women,s wellness ...
Breaking Medicine Technology: